M
Mark L. Robbins
Researcher at University of Rhode Island
Publications - 55
Citations - 4484
Mark L. Robbins is an academic researcher from University of Rhode Island. The author has contributed to research in topics: Transtheoretical model & Behavior change. The author has an hindex of 25, co-authored 52 publications receiving 4085 citations. Previous affiliations of Mark L. Robbins include Robert Wood Johnson University Hospital & Harvard University.
Papers
More filters
Journal ArticleDOI
2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
Dinesh Khanna,John FitzGerald,Puja P. Khanna,Sangmee Bae,Manjit K. Singh,Tuhina Neogi,Michael H. Pillinger,Joan Merill,Susan J. Lee,Shraddha Prakash,Marian Kaldas,Maneesh Gogia,Fernando Perez-Ruiz,William J. Taylor,Frédéric Lioté,Hyon K. Choi,Jasvinder A. Singh,Nicola Dalbeth,Sanford Kaplan,Vandana Dua Niyyar,Danielle Jones,Steven A. Yarows,Blake J. Roessler,Gail S. Kerr,Charles H. King,Gerald Levy,Daniel E. Furst,N. Lawrence Edwards,Brian F. Mandell,H. Ralph Schumacher,Mark L. Robbins,Neil S. Wenger,Robert Terkeltaub +32 more
TL;DR: DINESH KHanNA, JOHN D. FITZGERALD, PUJA P. KHANNA, SANGMEE BAE, MANJIT K. SINGH, TUHINA NEOGI, MICHAEL H. PILLINGER, JOAN MERILL, SUSAN LEE, SHRADDHA PRAKASH, MARIAN KALDAS, MANEESH GOGIA, FERNANDO PEREZ-RUI
Journal ArticleDOI
Rheumatoid Arthritis Disease Activity Measures: American College of Rheumatology Recommendations for Use in Clinical Practice
Jaclyn Anderson,Liron Caplan,Jinoos Yazdany,Mark L. Robbins,Tuhina Neogi,Kaleb Michaud,Kenneth G. Saag,James R. O'Dell,Salahuddin Kazi +8 more
TL;DR: The American College of Rheumatology as mentioned in this paper conducted a systematic review of the literature to identify rheumatoid arthritis (RA) disease activity measures using exclusion criteria, input from an Expert Advisory Panel and psychometric analysis, a list of potential measures was created.
Journal ArticleDOI
2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.
Dinesh Khanna,Puja P. Khanna,John FitzGerald,Manjit K. Singh,Sangmee Bae,Tuhina Neogi,Michael H. Pillinger,Joan Merill,Susan J. Lee,Shraddha Prakash,Marian Kaldas,Maneesh Gogia,Fernando Perez-Ruiz,William J. Taylor,Frédéric Lioté,Hyon K. Choi,Jasvinder A. Singh,Nicola Dalbeth,Sanford Kaplan,Vandana Dua Niyyar,Danielle Jones,Steven A. Yarows,Blake J. Roessler,Gail S. Kerr,Charles H. King,Gerald Levy,Daniel E. Furst,N. Lawrence Edwards,Brian F. Mandell,H. Ralph Schumacher,Mark L. Robbins,Neil S. Wenger,Robert Terkeltaub +32 more
TL;DR: These guidelines for the management and anti-inflammatory prophylaxis of acute attacks of gouty arthritis complements the manuscript on guidelines to treat hyperuricemia in patients with evidence of gouts and involves a diverse and international panel of experts.
Journal ArticleDOI
Guidelines for the management of rheumatoid arthritis: American College of Rheumatology Ad Hoc Committee on Clinical Guidelines
C. Kent Kwoh,Robert W. Simms,Larry G. Anderson,Diane M. Erlandson,Jerry M. Greene,Carolee Moncur,James R. O'Dell,Alison J. Partridge,W. Neal Roberts,Mark L. Robbins,Robert A. Yood,Matthew H. Liang +11 more
TL;DR: The goal of treatment is to arrest the disease and to achieve remission, and patients may still benefit from pharmacologic, nonpharmacologic, and if necessary, surgical interventions.
Journal ArticleDOI
Guidelines for monitoring drug therapy in rheumatoid arthritis: American College of Rheumatology Ad Hoc Committee on Clinical Guidelines
Robert W. Simms,C. Kent Kwoh,Larry G. Anderson,Diane M. Erlandson,Jerry M. Greene,Mittie Kelleher,James R. O'Dell,Alison J. Partridge,W. Neal Roberts,Mark L. Robbins,Robert A. Yood,Matthew H. Liang +11 more
TL;DR: The recommendations summarized in Table 1 are for basic monitoring in patients with uncomplicated RA, and additional monitoring may be appropriate for patients with comorbid disease, concurrent medication, or other risk factors.